Background A strong association between obstructive sleep apnea (OSA) and the risk for
cardiovascular and cerebrovascular diseases has been reported. Continuous positive …

Background The impact of treatment for obstructive sleep apnoea (OSA) on reduction of
cardiovascular risk is unclear. This study aimed to examine the effect of continuous positive …

Background Previous, largely uncontrolled studies demonstrated the substantial effects of
continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and …

Purpose Obstructive sleep apnea (OSA) is associated with increased levels of systemic
inflammatory markers, increased arterial stiffness, and endothelial dysfunction, which may …

Purpose Obstructive sleep apnea (OSA) is suggested to predispose to cardiovascular
disease (CVD) events. It is uncertain whether compliance to continuous positive airway …

OBJECTIVES: Obstructive sleep apnea (OSA) is associated with significant cardiovascular
(CV) morbidity. Continuous positive airway pressure (CPAP) is the standard treatment for …

Rationale: Randomized controlled trials of continuous positive airway pressure (CPAP) in
patients with obstructive sleep apnea (OSA) have not demonstrated protection against …

Reducing cardiometabolic risk may represent an important target for effective obstructive
sleep apnea (OSA) treatment. The impact of continuous positive airway pressure (CPAP) …

Background Obstructive sleep apnea is associated with hypertension, inflammation, and
increased cardiovascular risk. Continuous positive airway pressure (CPAP) reduces blood …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …